Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center

Lindsey-Yoojin CHUNG; Eungu KANG; Hyo-Kyoung NAM; Young-Jun RHIE; Kee-Hyoung LEE.
Journal of Korean Medical Science ; : e219-2021.
Artículo en Inglés | WPRIM | ID: wpr-899889

Documentos relacionados

  1. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center.
  2. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center
  3. Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study.
  4. Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty.
  5. A single blood sample for stimulated LH assayed by ICMA is useful for monitoring the treatment efficacy of triptorelin depot in girls.
  6. Triptorelin depot stimulation test for central precocious puberty.
  7. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
  8. Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.
  9. Assessment of Estradiol Response after Depot Triptorelin Administration in Girls with Central Precocious Puberty.
  10. A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.